nandrolone decanoate has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daga, MK; Hira, HS; Khan, NA; Kumar, S; Malhotra, V; Mawari, G | 1 |
Langen, RC; Pansters, NA; Schols, AM; Wouters, EF | 1 |
Creutzberg, EC; Mostert, R; Pluymers, RJ; Schols, AM; Wouters, EF | 1 |
3 trial(s) available for nandrolone decanoate and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Study of body composition, lung function, and quality of life following use of anabolic steroids in patients with chronic obstructive pulmonary disease.
Topics: Activities of Daily Living; Adult; Aged; Anabolic Agents; Anthropometry; Body Composition; Dietary Supplements; Double-Blind Method; Exercise Test; Humans; Lung; Male; Middle Aged; Nandrolone; Nandrolone Decanoate; Physical Fitness; Pulmonary Disease, Chronic Obstructive; Quality of Life; Walking | 2014 |
Synergistic stimulation of myogenesis by glucocorticoid and IGF-I signaling.
Topics: Aged; Anabolic Agents; Animals; Cell Line; Dexamethasone; Drug Synergism; Gene Expression Regulation; Glucocorticoids; Humans; Insulin-Like Growth Factor I; Male; Mice; Middle Aged; Models, Biological; Muscle Development; Muscle Fibers, Skeletal; Muscle Proteins; Nandrolone; Nandrolone Decanoate; Pulmonary Disease, Chronic Obstructive; Signal Transduction | 2013 |
A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial.
Topics: Aged; Anabolic Agents; Body Composition; Double-Blind Method; Erythropoiesis; Exercise Tolerance; Health Status; Humans; Injections, Intramuscular; Male; Muscle Weakness; Muscle, Skeletal; Nandrolone; Nandrolone Decanoate; Pulmonary Disease, Chronic Obstructive; Respiratory Muscles | 2003 |